DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,087,733 | +2.1% | 169,640 | -1.3% | 1.44% | +6.4% |
| Q2 2023 | $41,229,685 | -15.8% | 171,790 | -11.5% | 1.35% | -20.8% |
| Q1 2023 | $48,938,933 | -11.3% | 194,171 | -6.6% | 1.71% | -12.8% |
| Q4 2022 | $55,174,183 | -0.7% | 207,875 | -3.4% | 1.96% | -5.2% |
| Q3 2022 | $55,559,000 | -52.1% | 215,105 | -53.0% | 2.07% | -0.1% |
| Q2 2022 | $115,950,000 | +67.5% | 457,356 | +93.8% | 2.07% | -5.3% |
| Q1 2022 | $69,218,000 | -8.6% | 235,974 | +2.5% | 2.19% | -4.2% |
| Q4 2021 | $75,732,000 | +7.7% | 230,183 | -0.3% | 2.28% | -1.0% |
| Q3 2021 | $70,322,000 | +4.3% | 230,989 | -8.0% | 2.31% | +2.4% |
| Q2 2021 | $67,415,000 | +20.0% | 251,211 | +0.6% | 2.26% | +8.5% |
| Q1 2021 | $56,197,000 | +3.3% | 249,676 | +1.9% | 2.08% | +4.5% |
| Q4 2020 | $54,417,000 | +5.1% | 244,965 | +1.9% | 1.99% | -11.2% |
| Q3 2020 | $51,780,000 | +16.8% | 240,467 | -4.1% | 2.24% | +14.8% |
| Q2 2020 | $44,349,000 | +24.7% | 250,799 | -2.4% | 1.95% | +15.6% |
| Q1 2020 | $35,552,000 | -10.2% | 256,861 | -0.4% | 1.69% | +53.3% |
| Q4 2019 | $39,595,000 | +3.5% | 257,979 | -2.6% | 1.10% | +9.6% |
| Q3 2019 | $38,257,000 | +1.6% | 264,881 | +0.5% | 1.00% | +5.5% |
| Q2 2019 | $37,672,000 | +7.6% | 263,591 | -0.6% | 0.95% | +7.7% |
| Q1 2019 | $35,012,000 | +26.3% | 265,206 | -1.4% | 0.88% | +25.0% |
| Q4 2018 | $27,729,000 | -3.1% | 268,904 | +2.1% | 0.71% | +3.1% |
| Q3 2018 | $28,614,000 | +11.6% | 263,336 | +1.4% | 0.69% | +12.6% |
| Q2 2018 | $25,630,000 | +0.5% | 259,731 | -0.3% | 0.61% | -6.4% |
| Q1 2018 | $25,504,000 | +5.6% | 260,488 | +0.1% | 0.65% | +4.0% |
| Q4 2017 | $24,143,000 | +13.5% | 260,101 | +4.8% | 0.63% | +14.0% |
| Q3 2017 | $21,280,000 | +2.3% | 248,076 | +0.7% | 0.55% | -7.6% |
| Q2 2017 | $20,794,000 | +1.7% | 246,402 | +3.1% | 0.60% | -29.7% |
| Q1 2017 | $20,447,000 | +25.6% | 239,064 | +14.3% | 0.85% | -3.3% |
| Q4 2016 | $16,274,000 | -7.7% | 209,073 | -7.1% | 0.88% | -8.8% |
| Q3 2016 | $17,634,000 | -23.4% | 224,951 | -1.3% | 0.96% | -20.3% |
| Q2 2016 | $23,028,000 | +2.3% | 228,001 | -3.9% | 1.20% | -17.9% |
| Q1 2016 | $22,515,000 | -18.6% | 237,352 | -20.3% | 1.46% | +14.9% |
| Q4 2015 | $27,666,000 | +1.8% | 297,867 | -6.6% | 1.28% | -29.3% |
| Q3 2015 | $27,178,000 | -9.7% | 318,957 | -9.3% | 1.80% | -8.0% |
| Q2 2015 | $30,100,000 | -4.4% | 351,672 | -5.2% | 1.96% | +3.3% |
| Q1 2015 | $31,487,000 | -3.3% | 370,872 | -2.4% | 1.90% | -4.3% |
| Q4 2014 | $32,562,000 | +9.0% | 379,908 | -3.4% | 1.98% | +8.7% |
| Q3 2014 | $29,872,000 | +6.8% | 393,166 | +10.7% | 1.82% | +3.2% |
| Q2 2014 | $27,964,000 | +4.8% | 355,188 | -0.2% | 1.77% | -3.8% |
| Q1 2014 | $26,695,000 | -1.6% | 355,932 | +1.3% | 1.84% | -2.2% |
| Q4 2013 | $27,116,000 | +28.0% | 351,242 | +14.9% | 1.88% | +23.5% |
| Q3 2013 | $21,192,000 | +9.1% | 305,706 | -0.4% | 1.52% | +3.4% |
| Q2 2013 | $19,429,000 | – | 306,939 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |